BioHealth News
Gaithersburg’s Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407
GAITHERSBURG, Md., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced that the first participant has been dosed…
Read MoreMaryland Governor Wes Moore Addresses BioHealth Capital Region Forum at USP
The BioHealth Capital Region Forum had the honor of hosting Maryland Governor Wes Moore, who addressed attendees at the 10th Annual event held at…
Read MoreKeynotes and Presenters Drive the Conversation at BioHealth Capital Region Forum
The 10th Annual BioHealth Capital Region Forum has once again brought together some of the most influential leaders and innovators in the biohealth industry.…
Read MoreFast Company: Johns Hopkins Technology Ventures proves you don’t need to move to a tech hub. Just build your own
The commercialization and technology transfer arm of the storied Baltimore university is helping to foster the region’s burgeoning tech scene. BY Steven Melendez Attracting early-stage…
Read MoreVirginia Governor Glenn Youngkin Honored as BIO’s Governor of the Year at BioHealth Capital Region Forum
During the opening day of the BioHealth Capital Region Forum at US Pharmacopeia in Rockville on September 17th, 2024, Virginia Governor Glenn Youngkin was…
Read MoreMontgomery County Executive Marc Elrich Returns to the 10th Annual BioHealth Capital Region Forum, Celebrating a Decade of Innovation
Montgomery County Executive Marc Elrich helped kick off the 10th Annual BioHealth Capital Region Forum once again this year, reinforcing the county’s pivotal role…
Read MoreNIH awards $27M to establish new network of genomics-enabled learning health systems
Network will analyze and improve how genomic information is integrated into patient care. The National Institutes of Health (NIH) is awarding $5.4 million in…
Read MoreVerImmune Completes $4.5 Million First Closing of Pre-Series A Financing, Strengthens Board with Two Accomplished Biotechnology Executives
BETHESDA, Md. and SINGAPORE, Sept. 23, 2024 /PRNewswire/ -- VerImmune Inc., ("VerImmune"), a venture-backed biotechnology company developing a groundbreaking Virus-inspired Particle (ViP™) platform technology, today announced the successful…
Read More2024 Women’s Health Innovation Summit: Leading the Future of Women’s Healthcare
The 2024 Women’s Health Innovation Summit USA taking place from September 23-25, 2024, in Boston, MA. This event will serve as a leading platform…
Read MoreLeadership and Innovation Take the Stage at 10th Annual BioHealth Capital Region Week 2024
Day 1 Recap: A Dynamic Start to the 10th Annual BioHealth Capital Region Forum The 10th Annual BioHealth Capital Region Forum kicked off with…
Read MoreImmobazyme Travels from South Africa to Compete in the Crab Trap at BioHealth Capital Region Week 2024
BioHealth Capital Region Week 2024 welcomed Immobazyme, a biotech company from Stellenbosch, South Africa, to compete in the 9th Annual Crab Trap Competition. Specializing…
Read MoreLinshom Medical Wins 9th Annual Crab Trap Competition at BioHealth Capital Region Week
Linshom Medical, a TEDCO-backed company, located in Baltimore, MD, was named the winner of the 9th Annual Crab Trap Competition during the BioHealth Capital…
Read MoreBioHealth Innovation, Inc. and Georgetown University’s Office of Technology Commercialization Collaborate to Advance Venture Creation and Research Translation
ROCKVILLE, MARYLAND, September 23, 2024 – BioHealth Innovation, Inc. (BHI) and Georgetown University’s Office of Technology Commercialization (OTC) have entered into a strategic collaboration…
Read MoreTEDCO Invests in CarrTech Corp.
This biotechnology company aims to save lives through their transformative medical device. COLUMBIA, Md., (September 23, 2024) — TEDCO, Maryland’s economic engine for technology…
Read MoreAstraZeneca’s FluMist approved for self-administration in the US
WILMINGTON, Del., September 20, 2024 – FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray,…
Read More